T. Saab

P2-230: A Phase I Study of Nontoxic Suramin As A Chemosensitizer In Pretreated/Refractory Non-Small Cell Lung Cancer (NSCLC) Patients

T. Olencki, M. Wientjes, G. Otterson, 2007 .

Modulation of chemotherapy resistance with low dose suramin in refractory non-small cell lung cancer (NSCLC) patients: A phase I study of sequential non-cross resistant chemotherapy

T. Olencki, G. Otterson, A. Grainger, 2005 .

Failure of Normalization of CA19-9 Following Resection for Pancreatic Cancer is Tantamount to Metastatic Disease

M. Bloomston, W. Melvin, P. Muscarella, 2011, Annals of Surgical Oncology.

A Multicenter Phase II Study of Gemcitabine, Capecitabine, and Bevacizumab for Locally Advanced or Metastatic Biliary Tract Cancer

W. Ma, R. Iyer, A. Groman, 2016, American journal of clinical oncology.